Enacted January 1, 2010

For the policies on the research and publication ethics not stated in these instructions, Good Publication Practice Guidelines for Medical Journals available at:
https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page= or ‘Guidelines on good publication available at: http://www.publicationethics.org.uk/guidelines can be applied.

• 1. Conflict-of-interest statement

  Conflicts of interest must be disclosed in all submissions to International journal of Pain including General Articles, Case Reports, Review Articles, Medical Intelligence Articles, Special Articles and Editorials. Authors must define all funding sources supporting their work or its authors, and disclose commercial associations that might pose a conflict of interest in connection with the work submitted. Consultancies, equity interests, or patent-licensing arrangements should also be noted at submission.

• 2. Statement of informed consent

  Human experimentation must conform to ethical standards, and be approved by the appropriate Institutional Review Board (IRB). A statement concerning IRB approval and consent procedures must appear at the beginning of the Methods section. Any systematic data gathering effort in patients or volunteers must be approved by an IRB or adhere to appropriate local/national regulations. Authors may be questioned about the details of consent forms or the consent process. On occasion, the Editor-in-Chief may request a copy of the approved IRB application from the author.

• 3. Language

  It is recommended that manuscripts should be primarily written in English. However, manuscripts in Korean can be submitted if Citations, Acknowledgements, Tables, Figures and References are written in English and are translated in English after the final acceptance for publication. Medical terminology should be written in English only even in the manuscript written in Korean based on the recent edition of the Dorland’ Illustrated Medical Dictionary.

• 4. Statement of human and animal right

  Clinical research should be done in accordance with the Ethical Principles for Medical Research Involving Human Subjects outlined in the Helsinki Declaration in 1975 (revised 2000). Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects should not be identifiable. Patients’ name, initial, hospital number, date of birth, or other protected healthcare information should not be disclosed. For animal subjects, research should be performed based on National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be observed.

• 5. Authorship

  Authorship credit should be based on 1) substantial contributions to concept and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet the above three conditions. One of the authors should be designated to receive correspondence and proofs, and the appropriate address indicated. This author should take responsibility for keeping all other named authors informed of the paper’s progress. In addition, the corresponding author must ensure that there is no one else who fulfils the criteria but has not been included as an author. It is the responsibility of the corresponding author to ensure that authorship is agreed among the study’s workers, contributors of additional data and other interested parties, before submission of the manuscript.

• 6. Originality and duplicate publication

  All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. No part of the accepted manuscript should be duplicated in another scientific journal without permission by the Editorial Board. If duplicate publications related to the papers of this journal are detected, sanctions against authors range from requesting their institutions to assess the facts, requesting a Letter to the Editor-in-Chief acknowledging the error and voluntarily withdrawing a manuscript, to a ban on publication in International journal of Pain up to 3 years.

• 7. Secondary publication

  It is possible to republish manuscripts if the manuscripts satisfy the condition of secondary publication of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals available at: http://www.icmje.org.